1. Home
  2. HEI vs IQV Comparison

HEI vs IQV Comparison

Compare HEI & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HEI
  • IQV
  • Stock Information
  • Founded
  • HEI 1957
  • IQV 1982
  • Country
  • HEI United States
  • IQV United States
  • Employees
  • HEI N/A
  • IQV N/A
  • Industry
  • HEI Aerospace
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • HEI Industrials
  • IQV Health Care
  • Exchange
  • HEI Nasdaq
  • IQV Nasdaq
  • Market Cap
  • HEI 37.6B
  • IQV 31.6B
  • IPO Year
  • HEI N/A
  • IQV 2013
  • Fundamental
  • Price
  • HEI $258.83
  • IQV $167.17
  • Analyst Decision
  • HEI Buy
  • IQV Strong Buy
  • Analyst Count
  • HEI 11
  • IQV 18
  • Target Price
  • HEI $271.40
  • IQV $248.72
  • AVG Volume (30 Days)
  • HEI 460.6K
  • IQV 1.6M
  • Earning Date
  • HEI 05-27-2025
  • IQV 05-01-2025
  • Dividend Yield
  • HEI 0.08%
  • IQV N/A
  • EPS Growth
  • HEI 32.34
  • IQV 2.74
  • EPS
  • HEI 4.05
  • IQV 7.49
  • Revenue
  • HEI $3,991,528,000.00
  • IQV $15,405,000,000.00
  • Revenue This Year
  • HEI $12.56
  • IQV $4.25
  • Revenue Next Year
  • HEI $7.51
  • IQV $6.17
  • P/E Ratio
  • HEI $64.00
  • IQV $22.38
  • Revenue Growth
  • HEI 23.06
  • IQV 2.81
  • 52 Week Low
  • HEI $185.03
  • IQV $166.16
  • 52 Week High
  • HEI $283.60
  • IQV $252.88
  • Technical
  • Relative Strength Index (RSI)
  • HEI 49.39
  • IQV 30.96
  • Support Level
  • HEI $260.34
  • IQV $169.37
  • Resistance Level
  • HEI $272.97
  • IQV $188.39
  • Average True Range (ATR)
  • HEI 5.95
  • IQV 4.92
  • MACD
  • HEI -0.94
  • IQV -0.99
  • Stochastic Oscillator
  • HEI 16.97
  • IQV 3.29

About HEI Heico Corporation

Heico is an aerospace and defense supplier that focuses on creating niche replacement parts for commercial aircraft and components for defense products. In commercial aerospace, Heico is the largest independent producer of replacement aircraft parts. In the defense market, the company produces niche subcomponents used in targeting technology as well as simulation equipment, among other categories. It operates as two segments: the flight support group,or FSG, and the electronic technologies group, or ETG, both of which supply the aerospace and defense sectors to different degrees. The company is persistently acquisitive, focusing on companies in similar or adjacent markets that are generating strong cash flow and profitable growth potential.

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: